Logo
our product background

Our Products

Our Life Science Platform

Our platform modules facilitate in speeding up ai-driven drug discovery, more reliably and unbiased.

Ontosight<sup>&reg;</sup> Discover

Ontosight® Discover

Leverage AI to analyze information from the largest life sciences data ocean using our self-learning ontology for continuous, real-time insights.

Ontosight<sup>&reg;</sup> Explore

Ontosight® Explore

Visualize connections between biological entities using power maps and research graphs to discover potential drugs and targets.

Ontosight<sup>&reg;</sup> Influence

Ontosight® Influence

Get access to real-time discovery, network analysis. and management of top and emerging key opinion leaders (KOLs) and digital opinion leaders (DOLs).

Ontosight<sup>&reg;</sup> Integrate

Ontosight® Integrate

Optimize leadership strategy with real-time access to product performance, sales, budget and expenses, patient activity, CI landscape, etc.

Ontosight<sup>&reg;</sup> Dashboards

Ontosight® Dashboards

Obtain up-to-date, relevant information and insights generated from continuously crawled multiple publicly available sources in one place.

Looking for something?

We have a lot more. If you can’t find, reach out to us.

Connect with us

Our RWD-Exchange

Amrit AG

Our AI and Blockchain technologies aim at empowering patients to create value with their own data. To achieve this goal, we created an ecosystem comprising all potential stakeholders (i.e. CROs, BioTech, Patients) in the entire drug discovery process that will/can benefit.

Via our Apps Curia for Cancer and Neuria for Neurologic diseases, Real World Data is being provided and utilized. (questionnaires) via Curia App & Neuria App Physicians Dashboards Hospital Dashboards

Read More
speaker-icon
award

Innoplexus wins Horizon Interactive Gold Award for Curia App

Read More
ontosight ad illustration

Ontosight® Terminal

FREE for a limited time

Try now

We use first-party cookies to provide you the best possible experience. Necessary By clicking "Accept", you agree to the use of our cookies on your device.